→
Thermo Fisher Scientific Inc (TMO) is well-positioned for growth with a market cap of $167.89B and an impressive EPS growth of 6.66% year-over-year. The company's current price of $447.12 reflects a 52-week high of $643.99, indicating significant upside potential. Additionally, TMO's recent earnings have consistently beaten estimates, showcasing strong operational performance.
Investors should consider buying TMO stock as its long-term growth prospects remain promising despite short-term fluctuations.
Thermo Fisher has set a target for a 7% organic revenue CAGR and low-teens adjusted EPS growth in the long term, indicating robust growth potential. Additionally, the company has a strong analyst consensus with 11 Strong Buy ratings, suggesting confidence in its future performance.
Despite its positive outlook, TMO's current P/E ratio of 24.27 may indicate overvaluation compared to its peers in the Life Sciences Tools & Services sector. Furthermore, with a recent price drop of 1.03%, investor sentiment may be wavering, leading to potential volatility.
Want AI analysis of your entire portfolio?
Helm Terminal connects to your brokerage, analyzes every holding, and delivers actionable intelligence weekly.
Get started freeHelm provides financial data for informational purposes only. This is not financial, investment, or tax advice. Consult a qualified professional before making financial decisions.
Helm's AI rates TMO as Bullish. Investors should consider buying TMO stock as its long-term growth prospects remain promising despite short-term fluctuations.
Despite its positive outlook, TMO's current P/E ratio of 24.27 may indicate overvaluation compared to its peers in the Life Sciences Tools & Services sector. Furthermore, with a recent price drop of 1.03%, investor sentiment may be wavering, leading to potential volatility.
Thermo Fisher has set a target for a 7% organic revenue CAGR and low-teens adjusted EPS growth in the long term, indicating robust growth potential. Additionally, the company has a strong analyst consensus with 11 Strong Buy ratings, suggesting confidence in its future performance.
Thermo Fisher Scientific Inc (TMO) is well-positioned for growth with a market cap of $167.89B and an impressive EPS growth of 6.66% year-over-year. The company's current price of $447.12 reflects a 52-week high of $643.99, indicating significant upside potential. Additionally, TMO's recent earnings have consistently beaten estimates, showcasing strong operational performance.
Thermo Fisher Scientific Inc (TMO) is well-positioned for growth with a market cap of $167.89B and an impressive EPS growth of 6.66% year-over-year. The company's current price of $447.12 reflects a 52-week high of $643.99, indicating significant upside potential. Additionally, TMO's recent earnings have consistently beaten estimates, showcasing strong operational performance. Our overall verdict is Bullish.
Helm Terminal offers free AI-powered stock analysis for TMO at helmterminal.dev/analyze/TMO, updated continuously during US market hours. No signup required.
Helm's analysis is generated by an AI model from live market data. It identifies risk signals, opportunities, and key metrics based on current fundamentals, recent price action, and analyst consensus. It does not execute trades, issue certified investment advice, or predict future prices.
Not financial advice. Informational use only. AI-generated content may contain errors. Consult a licensed financial advisor before making investment decisions. Helm Terminal is not registered as an investment advisor.